Article
NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects.
Clinical cancer research : an official journal of the American Association for Cancer Research - 17 Jan 2023
Belhadj Sami, Khurram Aliya, Bandlamudi Chaitanya, Palou-Márquez Guillermo, Ravichandran Vignesh, Steinsnyder Zoe, Wildman Temima, Catchings Amanda, Kemel Yelena, Mukherjee Semanti, Fesko Benjamin, Arora Kanika, Mehine Miika, Dandiker Sita, Izhar Aalin, Petrini John, Domchek Susan, Nathanson Katherine L, Brower Jamie, Couch Fergus, Stadler Zsofia, Robson Mark, Walsh Michael, Vijai Joseph, Berger Michael, Supek Fran, Karam Rachid, Topka Sabine, Offit Kenneth
Abstract excerpt
PURPOSE: To explore the role of NBN as a pan-cancer susceptibility gene. EXPERIMENTAL DESIGN: Matched germline and somatic DNA samples from 34,046 patients were sequenced using Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets and presumed pathogenic germline variants (PGV) identified. Allele-specific and gene-centered analysis of enrichment was conducted and a validation cohort...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
